PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation

Reducing the incidence of graft-versus-host disease (GVHD) after haploidentical hematopoietic stem cell transplantation (HSCT) is warranted. Posttransplant cyclophosphamide (PTCy) is the main agent used for GVHD prevention in this setting. It remains unknown whether costimulation blockade can be saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Homsi, A. Samer, Cirrone, Frank, Wo, Stephanie, Cole, Kelli, Suarez-Londono, J. Andres, Gardner, Sharon L., Hsu, Jingmei, Stocker, Kelsey, Bruno, Benedetto, Goldberg, Judith D., Levinson, Benjamin A., Abdul-Hay, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368845/
https://www.ncbi.nlm.nih.gov/pubmed/37163349
http://dx.doi.org/10.1182/bloodadvances.2023010545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368845/
https://www.ncbi.nlm.nih.gov/pubmed/37163349
http://dx.doi.org/10.1182/bloodadvances.2023010545

Ejemplares similares